

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adhesion of symbiont to host cell (GO:0044650) | 8.77369593 |
| 2 | virion attachment to host cell (GO:0019062) | 8.77369593 |
| 3 | cellular extravasation (GO:0045123) | 7.91788647 |
| 4 | wound healing, spreading of epidermal cells (GO:0035313) | 7.82218183 |
| 5 | adhesion of symbiont to host (GO:0044406) | 7.66154407 |
| 6 | negative thymic T cell selection (GO:0045060) | 6.26024607 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.05700311 |
| 8 | negative T cell selection (GO:0043383) | 5.84688099 |
| 9 | wound healing, spreading of cells (GO:0044319) | 5.59282222 |
| 10 | pinocytosis (GO:0006907) | 5.37350376 |
| 11 | activated T cell proliferation (GO:0050798) | 5.29165786 |
| 12 | regulation of apoptotic cell clearance (GO:2000425) | 5.23680520 |
| 13 | lipoxygenase pathway (GO:0019372) | 5.21204053 |
| 14 | regulation of hypersensitivity (GO:0002883) | 5.11358841 |
| 15 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 5.04720544 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.99485943 |
| 17 | positive regulation of mast cell activation (GO:0033005) | 4.77649280 |
| 18 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 4.73520925 |
| 19 | mannose metabolic process (GO:0006013) | 4.73361462 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.64287929 |
| 21 | glycosphingolipid catabolic process (GO:0046479) | 4.53152452 |
| 22 | positive regulation of B cell differentiation (GO:0045579) | 4.43672785 |
| 23 | response to muramyl dipeptide (GO:0032495) | 4.36908679 |
| 24 | response to peptidoglycan (GO:0032494) | 4.32608125 |
| 25 | apoptotic cell clearance (GO:0043277) | 4.30995226 |
| 26 | positive thymic T cell selection (GO:0045059) | 4.30127732 |
| 27 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.29917547 |
| 28 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.29842463 |
| 29 | positive regulation of antigen processing and presentation (GO:0002579) | 4.29036503 |
| 30 | regulation of transforming growth factor beta1 production (GO:0032908) | 4.17640395 |
| 31 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.13979922 |
| 32 | positive regulation of mast cell degranulation (GO:0043306) | 4.11549378 |
| 33 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.11549378 |
| 34 | glycolipid catabolic process (GO:0019377) | 4.06606528 |
| 35 | thymic T cell selection (GO:0045061) | 4.06485669 |
| 36 | homeostasis of number of cells within a tissue (GO:0048873) | 3.99395520 |
| 37 | negative regulation of adaptive immune response (GO:0002820) | 3.99335607 |
| 38 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.86917558 |
| 39 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.82109050 |
| 40 | T cell selection (GO:0045058) | 3.80127042 |
| 41 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.80057462 |
| 42 | positive regulation of macrophage cytokine production (GO:0060907) | 3.79289932 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.74131503 |
| 44 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.67701015 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67028666 |
| 46 | negative regulation of type 2 immune response (GO:0002829) | 3.64934293 |
| 47 | ceramide catabolic process (GO:0046514) | 3.63749403 |
| 48 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.57520632 |
| 49 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.55297178 |
| 50 | positive regulation of chemokine secretion (GO:0090197) | 3.52318392 |
| 51 | regulation of type 2 immune response (GO:0002828) | 3.48178431 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.47400847 |
| 53 | positive regulation of type 2 immune response (GO:0002830) | 3.45271424 |
| 54 | negative regulation of granulocyte differentiation (GO:0030853) | 3.45265409 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.45007669 |
| 56 | B cell mediated immunity (GO:0019724) | 3.42590161 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41691236 |
| 58 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.39543470 |
| 59 | T-helper 1 type immune response (GO:0042088) | 3.39224300 |
| 60 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.37837228 |
| 61 | intracellular pH reduction (GO:0051452) | 3.36434436 |
| 62 | modulation by virus of host morphology or physiology (GO:0019048) | 3.36271863 |
| 63 | macrophage differentiation (GO:0030225) | 3.35939408 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35610372 |
| 65 | positive T cell selection (GO:0043368) | 3.34702131 |
| 66 | detection of bacterium (GO:0016045) | 3.32409911 |
| 67 | signal peptide processing (GO:0006465) | 3.31136826 |
| 68 | T cell costimulation (GO:0031295) | 3.30418597 |
| 69 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.29569022 |
| 70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28442531 |
| 71 | membrane lipid catabolic process (GO:0046466) | 3.27702176 |
| 72 | lymphocyte costimulation (GO:0031294) | 3.25713663 |
| 73 | sphingolipid catabolic process (GO:0030149) | 3.23363667 |
| 74 | positive regulation of urine volume (GO:0035810) | 3.19526848 |
| 75 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18704202 |
| 76 | pH reduction (GO:0045851) | 3.16783587 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 3.16332639 |
| 78 | detection of other organism (GO:0098543) | 3.15524807 |
| 79 | nerve growth factor signaling pathway (GO:0038180) | 3.12941244 |
| 80 | barbed-end actin filament capping (GO:0051016) | 3.12522968 |
| 81 | leukocyte cell-cell adhesion (GO:0007159) | 3.11771968 |
| 82 | positive regulation of leukocyte degranulation (GO:0043302) | 3.09551687 |
| 83 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09313812 |
| 84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09164335 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 3.06702482 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 3.04921594 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 3.04378325 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 3.00489591 |
| 89 | protein localization to endosome (GO:0036010) | 2.99733138 |
| 90 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.95930424 |
| 91 | myeloid cell development (GO:0061515) | 2.95380352 |
| 92 | protein targeting to vacuole (GO:0006623) | 2.94421219 |
| 93 | protein targeting to lysosome (GO:0006622) | 2.94421219 |
| 94 | establishment of protein localization to vacuole (GO:0072666) | 2.94421219 |
| 95 | viral genome replication (GO:0019079) | 2.92109728 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91310489 |
| 97 | regulation of chemokine secretion (GO:0090196) | 2.89975489 |
| 98 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.87317904 |
| 99 | icosanoid biosynthetic process (GO:0046456) | 2.82549670 |
| 100 | fatty acid derivative biosynthetic process (GO:1901570) | 2.82549670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.36988149 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.15699110 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.20787973 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.15294816 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.55145428 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.47370840 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35133270 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.11457531 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.95314986 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91636904 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87207995 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.60413821 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.56099068 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.49092039 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.47980414 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40496024 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.20737414 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.10461227 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.04863785 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01369983 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.00810904 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.98223078 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95177048 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94795804 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91083521 |
| 26 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.83048134 |
| 27 | * MYB_26560356_Chip-Seq_TH2_Human | 1.77278862 |
| 28 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75650890 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75495451 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70046508 |
| 31 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.66465106 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66301322 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65091861 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65081482 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.64817529 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63652391 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62285040 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.61430606 |
| 39 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58158198 |
| 40 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.56772444 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56081906 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.55691043 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52734769 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50802438 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50341170 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49243728 |
| 47 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48753108 |
| 48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48706467 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44976435 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40847427 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38941392 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35188046 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34925134 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.34065609 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32027290 |
| 56 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.31958361 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30278996 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29049094 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.28473116 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28014003 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.27429304 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27352400 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27122284 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23519971 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21646229 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20239729 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17678242 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15718844 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15494986 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12375488 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11321546 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09768953 |
| 73 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04671431 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02877398 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02529227 |
| 76 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01146267 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00356775 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99643442 |
| 79 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.97790231 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96819440 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96767597 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95770711 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95335085 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92755667 |
| 85 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91773697 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91538591 |
| 87 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.90988783 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90128718 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90012488 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87829186 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87721817 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85544516 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85508434 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84929608 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84749971 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83980076 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83906071 |
| 98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81841951 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81691247 |
| 100 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80126952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.16067048 |
| 2 | MP0003279_aneurysm | 4.49831419 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.47614114 |
| 4 | MP0001958_emphysema | 3.78796224 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.53959434 |
| 6 | MP0008004_abnormal_stomach_pH | 3.18841329 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.96647222 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.75113191 |
| 9 | MP0000015_abnormal_ear_pigmentation | 2.60676268 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.57485834 |
| 11 | MP0001790_abnormal_immune_system | 2.54573536 |
| 12 | MP0005387_immune_system_phenotype | 2.54573536 |
| 13 | MP0002419_abnormal_innate_immunity | 2.54198486 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.50908587 |
| 15 | MP0004947_skin_inflammation | 2.50664526 |
| 16 | MP0005647_abnormal_sex_gland | 2.31539695 |
| 17 | MP0005025_abnormal_response_to | 2.29552924 |
| 18 | MP0005174_abnormal_tail_pigmentation | 2.25159410 |
| 19 | MP0005166_decreased_susceptibility_to | 2.18323076 |
| 20 | MP0001853_heart_inflammation | 2.16822128 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.98777842 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.95476245 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.91981348 |
| 24 | MP0000343_altered_response_to | 1.90426947 |
| 25 | MP0002405_respiratory_system_inflammati | 1.88462828 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.88452577 |
| 27 | MP0003075_altered_response_to | 1.79857998 |
| 28 | MP0006082_CNS_inflammation | 1.73146660 |
| 29 | MP0003436_decreased_susceptibility_to | 1.72029718 |
| 30 | MP0001819_abnormal_immune_cell | 1.66071761 |
| 31 | MP0002971_abnormal_brown_adipose | 1.64401643 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.63882937 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.63584944 |
| 34 | MP0001849_ear_inflammation | 1.59735443 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.54734031 |
| 36 | MP0009115_abnormal_fat_cell | 1.54349125 |
| 37 | MP0000685_abnormal_immune_system | 1.53883105 |
| 38 | MP0002723_abnormal_immune_serum | 1.53076344 |
| 39 | MP0001727_abnormal_embryo_implantation | 1.50692122 |
| 40 | MP0001800_abnormal_humoral_immune | 1.50461930 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.50071643 |
| 42 | MP0003303_peritoneal_inflammation | 1.49701107 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.42614109 |
| 44 | MP0005670_abnormal_white_adipose | 1.42309535 |
| 45 | MP0003828_pulmonary_edema | 1.41010194 |
| 46 | MP0000371_diluted_coat_color | 1.40349607 |
| 47 | MP0000920_abnormal_myelination | 1.35880397 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.29745921 |
| 49 | MP0005451_abnormal_body_composition | 1.28835507 |
| 50 | MP0000716_abnormal_immune_system | 1.24399776 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.22663131 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.22663131 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.20438601 |
| 54 | MP0002398_abnormal_bone_marrow | 1.17003172 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.09772114 |
| 56 | MP0000604_amyloidosis | 1.09250519 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.05417018 |
| 58 | MP0001851_eye_inflammation | 1.04418088 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.04033702 |
| 60 | MP0002796_impaired_skin_barrier | 1.01491877 |
| 61 | MP0008874_decreased_physiological_sensi | 1.01382562 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.00452062 |
| 63 | MP0003448_altered_tumor_morphology | 0.99018550 |
| 64 | MP0003091_abnormal_cell_migration | 0.98914689 |
| 65 | MP0006138_congestive_heart_failure | 0.97379477 |
| 66 | MP0002722_abnormal_immune_system | 0.97348810 |
| 67 | MP0000689_abnormal_spleen_morphology | 0.96405506 |
| 68 | MP0002429_abnormal_blood_cell | 0.96383738 |
| 69 | MP0000858_altered_metastatic_potential | 0.95862127 |
| 70 | MP0009785_altered_susceptibility_to | 0.95112701 |
| 71 | MP0004381_abnormal_hair_follicle | 0.95057846 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.93560314 |
| 73 | MP0008469_abnormal_protein_level | 0.88071553 |
| 74 | MP0003724_increased_susceptibility_to | 0.85156791 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.83625643 |
| 76 | MP0002396_abnormal_hematopoietic_system | 0.83221958 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 0.83095854 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.81786414 |
| 79 | MP0005388_respiratory_system_phenotype | 0.80805068 |
| 80 | MP0002133_abnormal_respiratory_system | 0.80805068 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.77423748 |
| 82 | MP0002075_abnormal_coat/hair_pigmentati | 0.74262438 |
| 83 | MP0005409_darkened_coat_color | 0.73426222 |
| 84 | MP0010329_abnormal_lipoprotein_level | 0.73170876 |
| 85 | MP0002166_altered_tumor_susceptibility | 0.71427216 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.70632149 |
| 87 | MP0003763_abnormal_thymus_physiology | 0.70162174 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.69952026 |
| 89 | MP0008260_abnormal_autophagy | 0.69605059 |
| 90 | MP0010307_abnormal_tumor_latency | 0.68062310 |
| 91 | MP0004742_abnormal_vestibular_system | 0.67705245 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.67438776 |
| 93 | MP0001542_abnormal_bone_strength | 0.63348177 |
| 94 | MP0005334_abnormal_fat_pad | 0.62877494 |
| 95 | MP0003634_abnormal_glial_cell | 0.61863101 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.61790832 |
| 97 | MP0000249_abnormal_blood_vessel | 0.61326926 |
| 98 | MP0005310_abnormal_salivary_gland | 0.61077729 |
| 99 | MP0002970_abnormal_white_adipose | 0.58926906 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.58727211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.29641204 |
| 2 | Abnormality of macrophages (HP:0004311) | 5.96385246 |
| 3 | Recurrent cutaneous fungal infections (HP:0011370) | 5.71906654 |
| 4 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.71906654 |
| 5 | Esophageal varix (HP:0002040) | 5.67093482 |
| 6 | Protuberant abdomen (HP:0001538) | 5.15110207 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 4.37877394 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.33441834 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.26859240 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.26859240 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.26859240 |
| 12 | Recurrent skin infections (HP:0001581) | 4.21289348 |
| 13 | Steatorrhea (HP:0002570) | 4.20990293 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.09156884 |
| 15 | Hypercholesterolemia (HP:0003124) | 3.95582211 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.87474161 |
| 17 | Upper motor neuron abnormality (HP:0002127) | 3.73187048 |
| 18 | Hepatosplenomegaly (HP:0001433) | 3.72617152 |
| 19 | Loss of speech (HP:0002371) | 3.42318957 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.41577758 |
| 21 | Axonal loss (HP:0003447) | 3.39746509 |
| 22 | Polygenic inheritance (HP:0010982) | 3.38029332 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.33081665 |
| 24 | Multiple lipomas (HP:0001012) | 3.27889372 |
| 25 | Cheilitis (HP:0100825) | 3.22630762 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.16590958 |
| 27 | Mutism (HP:0002300) | 3.09432628 |
| 28 | Fat malabsorption (HP:0002630) | 2.97071705 |
| 29 | Meningitis (HP:0001287) | 2.92417622 |
| 30 | Disinhibition (HP:0000734) | 2.90673003 |
| 31 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.86923394 |
| 32 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.76656443 |
| 33 | Amyloidosis (HP:0011034) | 2.76427214 |
| 34 | Thoracic kyphosis (HP:0002942) | 2.69204493 |
| 35 | Albinism (HP:0001022) | 2.64105135 |
| 36 | Abdominal distention (HP:0003270) | 2.63801254 |
| 37 | Agnosia (HP:0010524) | 2.58445205 |
| 38 | Xerostomia (HP:0000217) | 2.56900182 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.54789352 |
| 40 | Scanning speech (HP:0002168) | 2.54637381 |
| 41 | Flat cornea (HP:0007720) | 2.50507304 |
| 42 | Cortical dysplasia (HP:0002539) | 2.50454370 |
| 43 | Hemoptysis (HP:0002105) | 2.50308676 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.47809542 |
| 45 | Colitis (HP:0002583) | 2.41839125 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.38797709 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.37658258 |
| 48 | Progressive visual loss (HP:0000529) | 2.35196740 |
| 49 | Thick nail (HP:0001805) | 2.27274193 |
| 50 | Obstructive lung disease (HP:0006536) | 2.26734309 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26734309 |
| 52 | Premature loss of primary teeth (HP:0006323) | 2.26067403 |
| 53 | Abnormality of the lumbar spine (HP:0100712) | 2.23669670 |
| 54 | Viral hepatitis (HP:0006562) | 2.23666511 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.23538730 |
| 56 | Spondylolisthesis (HP:0003302) | 2.22099920 |
| 57 | Pustule (HP:0200039) | 2.18464781 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18362226 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.15220049 |
| 60 | Ventricular fibrillation (HP:0001663) | 2.14923834 |
| 61 | Mucosal telangiectasiae (HP:0100579) | 2.13068870 |
| 62 | Adactyly (HP:0009776) | 2.13041744 |
| 63 | Peripheral hypomyelination (HP:0007182) | 2.12244765 |
| 64 | Pulmonary hypertension (HP:0002092) | 2.11539710 |
| 65 | Personality changes (HP:0000751) | 2.06730103 |
| 66 | Pruritus (HP:0000989) | 2.06160660 |
| 67 | Osteolytic defects of the hand bones (HP:0009699) | 2.05324041 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05324041 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.03304461 |
| 70 | Supernumerary nipples (HP:0002558) | 2.02524496 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 12.8522721 |
| 72 | Abnormality of the peritoneum (HP:0002585) | 1.99496996 |
| 73 | Hypertensive crisis (HP:0100735) | 1.99471432 |
| 74 | Basal ganglia calcification (HP:0002135) | 1.99435049 |
| 75 | Diminished motivation (HP:0000745) | 1.99045041 |
| 76 | Hematochezia (HP:0002573) | 1.96921163 |
| 77 | Purpura (HP:0000979) | 1.96417255 |
| 78 | Apathy (HP:0000741) | 1.94675834 |
| 79 | Acrocyanosis (HP:0001063) | 1.94663716 |
| 80 | Increased IgE level (HP:0003212) | 1.94403366 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93204034 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93204034 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93204034 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 1.89736688 |
| 85 | Recurrent viral infections (HP:0004429) | 1.89469074 |
| 86 | Mucopolysacchariduria (HP:0008155) | 1.88543502 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88543502 |
| 88 | Cardiomegaly (HP:0001640) | 1.86688725 |
| 89 | Bulbar palsy (HP:0001283) | 1.85610483 |
| 90 | Abnormality of the thoracic spine (HP:0100711) | 1.85398100 |
| 91 | Onion bulb formation (HP:0003383) | 1.85279238 |
| 92 | Amaurosis fugax (HP:0100576) | 1.83071533 |
| 93 | Glomerulonephritis (HP:0000099) | 1.83021993 |
| 94 | Absent hand (HP:0004050) | 1.80455835 |
| 95 | Thin bony cortex (HP:0002753) | 1.79890176 |
| 96 | Abnormality of the periventricular white matter (HP:0002518) | 1.77008250 |
| 97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76029730 |
| 98 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70912752 |
| 99 | Femoral bowing (HP:0002980) | 1.70455276 |
| 100 | Global brain atrophy (HP:0002283) | 1.68944122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.55110479 |
| 2 | MAP3K13 | 3.36024886 |
| 3 | MAP3K14 | 3.12723348 |
| 4 | TYK2 | 3.00206316 |
| 5 | RIPK4 | 2.78974699 |
| 6 | NEK9 | 2.74478794 |
| 7 | TTN | 2.69178904 |
| 8 | CSF1R | 2.65338837 |
| 9 | JAK3 | 2.45351769 |
| 10 | FES | 2.27160951 |
| 11 | PRPF4B | 2.24756342 |
| 12 | GRK7 | 2.24087498 |
| 13 | CSK | 2.21472088 |
| 14 | ITK | 2.18562746 |
| 15 | CAMK1D | 2.10246003 |
| 16 | CDC42BPA | 2.08012163 |
| 17 | PIK3CG | 1.91417061 |
| 18 | CAMKK2 | 1.88045867 |
| 19 | CAMK1G | 1.87765347 |
| 20 | CDK6 | 1.74010108 |
| 21 | EEF2K | 1.71724424 |
| 22 | LIMK1 | 1.69573360 |
| 23 | CAMKK1 | 1.64606567 |
| 24 | BTK | 1.61995300 |
| 25 | KSR2 | 1.58156446 |
| 26 | MOS | 1.53004217 |
| 27 | RPS6KA2 | 1.51105356 |
| 28 | DAPK2 | 1.47216974 |
| 29 | SYK | 1.41435943 |
| 30 | STK24 | 1.40799420 |
| 31 | ZAP70 | 1.40739768 |
| 32 | TRIB3 | 1.37715823 |
| 33 | MAP4K1 | 1.37280078 |
| 34 | HCK | 1.33711889 |
| 35 | TRPM7 | 1.28341220 |
| 36 | PRKCQ | 1.23052833 |
| 37 | ARAF | 1.21028969 |
| 38 | TEC | 1.12726717 |
| 39 | JAK2 | 1.12719951 |
| 40 | MAPK12 | 1.09330619 |
| 41 | ADRBK2 | 1.03960812 |
| 42 | PIM2 | 1.03958111 |
| 43 | MAP3K6 | 1.00487148 |
| 44 | MAP3K2 | 0.99340907 |
| 45 | YES1 | 0.98561967 |
| 46 | SGK3 | 0.98020349 |
| 47 | PDPK1 | 0.93817262 |
| 48 | MAPK7 | 0.93711721 |
| 49 | SMG1 | 0.92491804 |
| 50 | PDK1 | 0.91011333 |
| 51 | LCK | 0.89737000 |
| 52 | JAK1 | 0.88223674 |
| 53 | LYN | 0.83737309 |
| 54 | FGR | 0.83289927 |
| 55 | RPS6KL1 | 0.81697843 |
| 56 | RPS6KC1 | 0.81697843 |
| 57 | MAP3K1 | 0.81565462 |
| 58 | MAPKAPK3 | 0.81406142 |
| 59 | CDK12 | 0.80528368 |
| 60 | MAP3K8 | 0.80115034 |
| 61 | MAP3K9 | 0.78144858 |
| 62 | SGK2 | 0.76984070 |
| 63 | RAF1 | 0.75447847 |
| 64 | TESK2 | 0.73605630 |
| 65 | TGFBR2 | 0.70195350 |
| 66 | MAP3K5 | 0.67370884 |
| 67 | RPS6KA6 | 0.65503180 |
| 68 | RET | 0.63614052 |
| 69 | PKN2 | 0.61198248 |
| 70 | TBK1 | 0.60010758 |
| 71 | DAPK3 | 0.58751271 |
| 72 | IKBKB | 0.58632833 |
| 73 | PTK2B | 0.58165262 |
| 74 | MAPKAPK2 | 0.55503122 |
| 75 | MAPKAPK5 | 0.55022139 |
| 76 | CAMK4 | 0.52940021 |
| 77 | KSR1 | 0.52748416 |
| 78 | MAP2K4 | 0.51341415 |
| 79 | NME2 | 0.49516097 |
| 80 | RPS6KB1 | 0.49148132 |
| 81 | ERN1 | 0.48482322 |
| 82 | DAPK1 | 0.47255063 |
| 83 | GSK3A | 0.42138904 |
| 84 | ABL1 | 0.42071572 |
| 85 | PRKACB | 0.40801555 |
| 86 | MAP2K1 | 0.37468107 |
| 87 | CDK4 | 0.35826678 |
| 88 | FYN | 0.35810339 |
| 89 | RPS6KA1 | 0.33966983 |
| 90 | ROCK1 | 0.33100864 |
| 91 | PDGFRB | 0.32997681 |
| 92 | PRKG2 | 0.32980868 |
| 93 | IGF1R | 0.32307778 |
| 94 | TAF1 | 0.31044669 |
| 95 | SRC | 0.30896197 |
| 96 | SGK494 | 0.30305504 |
| 97 | SGK223 | 0.30305504 |
| 98 | STK3 | 0.29886185 |
| 99 | MAP3K3 | 0.29881961 |
| 100 | PRKACG | 0.28855658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 4.30005947 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.87383852 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.75150843 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.22238797 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.19308918 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.01851399 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80165088 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.79723069 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.79383685 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.77524686 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.66943196 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41367009 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.29489283 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 2.23441126 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 2.17994475 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94486891 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.88804151 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83007140 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77257650 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72377944 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61140867 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49810685 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43791410 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36340764 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32398178 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31488991 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27247223 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26493045 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10643462 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10354674 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.08122877 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06057435 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 0.99548325 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96541217 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86303833 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 0.84536113 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82700843 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82101628 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 0.80985472 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79178264 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 0.78281975 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77980184 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 0.73939959 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.73525810 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72250743 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71058660 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68473745 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.67046060 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65559574 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65382479 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64524022 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64433203 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.63541567 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62392928 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60120134 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59952030 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59515481 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56641284 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55510537 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.52411930 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51548235 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51087068 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49059439 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47885318 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47568790 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46825537 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.45860127 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45422754 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43468084 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.41829080 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41438048 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40484121 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40051943 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38711354 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38286142 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37879858 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36000764 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35929375 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34968104 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.34930252 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34572132 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34376763 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.33022785 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32989837 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32568836 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32408369 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32009957 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31933741 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31517460 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31393480 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.31030157 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30670066 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30292105 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30227392 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29936981 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29694978 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28457022 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27784964 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26018698 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23116644 |

